A phase I–II controlled randomized trial using a promising novel cell-free formulation for articular cartilage regeneration as treatment of severe osteoarthritis of the knee
Abstract Background: A promising novel cell‑free bioactive formulation for articular cartilage regeneration, called BIOF2, has recently been tested in pre‑clinical trials. The aim of the present study was to evaluate the efficacy and safety of BIOF2 for intra‑articular application in patients with s...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | http://eprints.uanl.mx/15983/1/56.pdf |